Combining opioids and non-opioids for pain management: Current status

Area of Science:

• Pharmacology
• Pain Management
• Drug Development

Background:

• Opioid analgesics, specifically μ-opioid receptor (MOR) agonists, are highly effective for pain but associated with severe adverse effects.
• The ongoing opioid overdose epidemic necessitates the development of safer pain management alternatives.
• Current pain management often relies on MOR agonists and NSAIDs, with limitations in efficacy and safety.

Purpose of the Study:

• To review recent advancements in combination therapy for pain management.
• To explore the potential of combining MOR agonists with non-MOR agonists to improve analgesic outcomes.
• To address the challenges of opioid dependence, abuse, and side effects through innovative therapeutic strategies.

Main Methods:

• Literature review of recent studies on combination analgesics.
• Analysis of pharmacological data on MOR agonists and non-MOR agonists.
• Synthesis of evidence regarding the efficacy and safety of combined pain therapies.

Main Results:

• Combination therapy can potentially enhance analgesic potency compared to monotherapy.
• Combining MOR agonists with non-MOR agonists may reduce tolerance, dependence, and abuse.
• This approach may mitigate side effects like constipation associated with prolonged opioid use.
• Recent developments show promise in improving the overall therapeutic profile of MOR agonists.

Conclusions:

• Combination therapy represents a viable strategy to improve the safety and efficacy of pain management.
• Further research into novel combinations could lead to safer and more effective analgesics.
• This approach offers a potential solution to the opioid crisis by reducing reliance on high-dose opioids.